Skip to main content
. 2016 Dec 2;2016(1):217–225. doi: 10.1182/asheducation-2016.1.217

Figure 3.

Figure 3.

Mechanism-of-action of eculizumab, a humanized monoclonal antibody that binds to C5 with a high affinity and inhibits cleavage of C5 by C5 convertase, and prevents generation of C5a and formation of C5b-9 MAC.